Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · STALLION IND FLUOROCHEM L · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
STALLION IND FLUOROCHEM L
NSE: STALLION · BSE: 544342
Commodities › Chemicals › Chemicals & Petrochemicals › Industrial Gases

STALLION IND FLUOROCHEM L

StateQ1 FY27 filed
Last close · 27 Oct 2026₹184.26
Market cap₹2.1k cr
TTM P/E · P/B · EV/EBITDA32.0 · 3.14 · 27.1

Manufactures and trades fluorochemicals, refrigerants, specialty gases (including helium and semiconductor gases), and HFO blends from four operating facilities in India, with two more under construction. The Bhilwara plant in Rajasthan, a 10,000 MT R-32 refrigerant facility, has received environmental clearance and is targeted to start production in October 2026. The Khalapur liquid helium and semiconductor gas plant is in final testing, targeted to start up by June 2026 with 1,200 MT annual capacity, sourcing helium through a partnership with Sharjah Oxygen Company. The Mumbattu facility in Andhra Pradesh is a 12-tank full-service operation for South India, scaled 2.5x beyond the original IPO scope, handling HFO/HFC blending, de-bulking, helium and semiconductor gas; it is targeted for August 2026 commissioning. Distribution runs through a pan-India network serving the refrigerant aftermarket plus electronics, semiconductor, healthcare and solar sectors. FY26 revenue was INR 434.12 crore (+14.4% YoY), with materials accounting for 85.7% of revenue and EBITDA margin at 14.2%. An additional HFO manufacturing plant is planned post mid-2027 with INR 400 crore total capex. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Refrigerants and fluorochemicals, Specialty gases, HFO blending and de-bulking services. Cyclical, asset-heavy fluorochemicals and specialty gases manufacturer

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY25–FY26 (all audited; no estimate years)

₹ crore · standaloneFY25FY26
Revenue377431
EBITDA (ex other income)4858
margin %12.613.4
Owners' profit3244
EPS, as reported (₹)4.985.34
ROE % · ROCE %10.7 · 16.16.4 · 8.8
Debt / equity (x)0.010.05
Cash from operations(13)39
Capex(5)(49)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · STALLION IND FLUOROCHEM L · 28 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 7 quarters

₹ croreQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue85152110106105110121
Profit before tax12181415131725
Net profit10131011111119
EPS (₹)1.591.761.311.421.401.331.60
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
LINDE INDIA LIMITED48,10088.011.2751.812.914.8—29.7
ELLENBARRIE INDUS GASES L4,46937.04.57—10.712.2—55.4
STALLION IND FLUOROCHEM L ◆2,14032.03.14—6.48.7—20.8
Hilltone Software and Gases Lt5379.42.29—0.6(0.4)—(3.5)
NATIONAL OXYGEN LTD.2915.9——(30.1)10.1—(18.9)
GAGAN GASES LTD.937.02.72—4.04.7—10.2
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/E (TTM)32.021.2135 of 19732%
P/B3.12.1135 of 20233%
ROCE8.78.1106 of 22052%
ROE6.47.3107 of 20247%
Debt / Equity0.10.268 of 20267%
EBITDA margin20.814.056 of 20173%
Revenue growth9.917.2124 of 19436%
Profit growth79.341.975 of 20263%
Market cap214038456 of 22575%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · STALLION IND FLUOROCHEM L · 28 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
16 Oct 2026 · Stallion India to meet ICICI Securities, Kotak and Nuvama on Oct 21-22board shareholder meetingslow——
15 Oct 2026 · GST Search at Registered Office; Company Says No Material Impactregulatory legalhigh——
7 Oct 2026 · Submission of Regulation 74(5) Certificate for Q2 FY27complianceminimal——
6 Oct 2026 · Reg 74(5) RTA Certificate for Q2 FY27complianceminimal——
29 Sept 2026 · Revised schedule for investor meetings on 1 October 2026board shareholder meetingslow——
28 Sept 2026 · Stallion India Fluorochemicals to hold virtual investor/analyst meet on Oct 1board shareholder meetingslow——
28 Sept 2026 · Trading Window closed from Oct 1, 2026 ahead of Q2 resultscomplianceminimal——
22 Sept 2026 · All 3 AGM resolutions passed with over 99.98 percent approvalboard shareholder meetingslow——
21 Sept 2026 · 24th AGM proceedings: 3 resolutions tabled for e-votingboard shareholder meetingsmedium——
19 Sept 2026 · Starts commercial ops at Semiconductor and Specialty Gas facility in Khalapurcapex operationshigh——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in